Matthias Orth

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Ejection Fraction

Quality Improvement

Top Venues

Clinical chemistry and laboratory medicine

Journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Patti Shih, Sverre Sandberg, Jan Balla, Banu Isbilen Basok, Jennifer J Brady, Bernard Croal, Nathalie De Vos, Mathias Karlsson, Piret Kedars, Tomris Ozben, Marina Pijanovic, Maria Rosaria Capobianchi, Matthias Orth
Direct-to-consumer testing as consumer initiated testing: compromises to the testing process and opportunities for quality improvement. Clinical chemistry and laboratory medicine (2024)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine 61 (4) (2023)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine 61 (4) (2023)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine (2023)
Florent J L A Vanstapel, Matthias Orth, Thomas Streichert, Ettore Domenico Capoluongo, Wytze P Oosterhuis, Hikmet Can Cubukcu, Francisco A Bernabeu-Andreu, Marc H M Thelen, Leo H J Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M M Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M Cobbaert, Michael Neumaier
ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro -Diagnostics Regulation. Clinical chemistry and laboratory medicine 61 (4) (2023)
Matthias Orth, Erik Vollebregt, Tomaso Trenti, Patti Shih, Mette Tollanes, Sverre Sandberg
Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine. Clinical chemistry and laboratory medicine 61 (4) (2022)
Matthias Orth, Erik Vollebregt, Tomaso Trenti, Patti Shih, Mette Tollanes, Sverre Sandberg
Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine. Clinical chemistry and laboratory medicine 61 (4) (2022)
Matthias Orth, Erik Vollebregt, Tomaso Trenti, Patti Shih, Mette Tollanes, Sverre Sandberg
Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine. Clinical chemistry and laboratory medicine (2022)
Matthias Orth, Erik Vollebregt, Tomaso Trenti, Patti Shih, Mette Tollanes, Sverre Sandberg
Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine. Clinical chemistry and laboratory medicine 61 (4) (2022)
Matthias Orth
Direct to Consumer Laboratory Testing (DTCT) - Opportunities and Concerns. EJIFCC 32 (2) (2021)
Christa M Cobbaert, Ettore D Capoluongo, Florent J L A Vanstapel, Patrick M M Bossuyt, Harjit Pal Bhattoa, Peter Henrik Nissen, Matthias Orth, Thomas Streichert, Ian S Young, Elizabeth Macintyre, Alan G Fraser, Michael Neumaier
Implementation of the new EU IVD regulation - urgent initiatives are needed to avert impending crisis. Clinical chemistry and laboratory medicine (2021)
Adrian Hoenle, Karin Johanna Haase, Sebastian Maus, Manfred Hofmann, Matthias Orth
Avoiding insufficient therapies and overdosing with co-reporting eGFRs (estimated glomerular filtration rate) for personalized drug therapy and improved outcomes - a simulation of the financial benefits. EJIFCC 32 (1) (2021)
Matthias Orth, Maria Averina, Stylianos Chatzipanagiotou, Gilbert Faure, Alexander Haushofer, Vesna Kusec, Augusto Machado, Siraj A Misbah, Wytze Oosterhuis, Kari Pulkki, Patrick J Twomey, Eberhard Wieland
Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy ('4P medicine'). Journal of clinical pathology 72 (3) (2017)
Matthias Orth
Are regulation-driven performance criteria still acceptable? - The German point of view. Clinical chemistry and laboratory medicine 53 (6) (2016)